Christopher Hite
CIK 1814238 · EVP & Vice Chairman · last filed 2026-05-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$42.77M
Companies
4
Total Filings
15
Lifetime Open-Market Net
$1.96M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPRX | EVP & Vice Chairman | 779,399 | $54.87 | $42.77M | $1.96M | 10 | 2026-05-08 |
| KLRA | Director | — | — | — | $0 | 1 | 2026-04-20 |
| VERA | Director | — | $34.26 | — | $0 | 1 | 2026-03-09 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 0 | $178.75 | $0 | $0 | 3 | 2021-11-22 |
Recent Filings · Page 2 of 2
15 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-22 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −930 | $0 | EDGAR |
| 2021-03-25 | RPRX | Sell (S) | — | $0 | EDGAR |
| 2021-02-02 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +930 | $0 | EDGAR |
| 2020-06-23 | RPRX | Mixed | +70,000 | $1.96M | EDGAR |
| 2020-06-05 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.